Directory of Service

Horizon scanning is the process of looking ahead to spot new and emerging developments in healthcare—like new technologies, treatments, or diagnostic tests—before they become widely used.

Why is it important?

−

It helps health systems prepare early—so they’re not caught off guard.
It supports better decisions about which innovations to invest in.
It can guide research, regulation, and funding toward the most promising ideas.

In short, horizon scanning is like a radar for healthcare innovation—it helps people see what’s coming so they can act early and wisely.

The following teams provide services to support this phase of diagnostic development. Click each team below to find out more.

NIHR Innovation Observatory

−

The NIHR Innovation Observatory is a world leading health and care innovation scanning centre, providing data-driven insights to foster innovation and equitable access to high-quality care. For more information see: https://io.nihr.ac.uk/

Health Innovation North East North Cumbria

+

Health Innovation North East North Cumbria provide resources for horizon scanning activities, utilising their innovation pathway. For further information please see: https://healthinnovationnenc.org.uk/

Basic research is used to gather information to improve our understanding of fundamental principles but has no immediate health & care application. The process of taking discoveries made in the lab and turning them into real diagnostic tests is known as “translational research”.

Purpose

−

The purpose of basic research is to focus on how things work at a molecular, cellular, genetic or systems level. This builds a knowledge base that later informs applied research to translate ideas into innovative new diagnostics. Activities may include:

Literature reviews, disease biology research
Biomarker discovery (e.g. genomics, proteomics)
Proof-of-concept studies in lab models or using biobanks.
Medical imaging

Basic research may fall under a specific theme – for example mitochondrial or neuromuscular disease, neuroscience, precision medicine/genomics or neurodegeneration.

The following teams provide services to support this phase of diagnostic development. Click each team below to find out more.

Newcastle University Research Facilities

−

The Newcastle University Research Facilities offer a wide range of laboratory services to support basic & applied research.

Newcastle University Core Genomics Facility – Offering state of the art next-generation sequencing (NGS) service provider specialising in single-cell applications. For more information, please see: https://www.ncl.ac.uk/GCF
Newcastle Magnetic Resonance Imaging Centre – Offering Magnetic Resonance Imaging (MRI services). For more information, please see: https://www.ncl.ac.uk/magres
Newcastle Central Biobank Facility – Provides biobanking services to facilitate basic and translational research. Please see: http://www.ncl.ac.uk/biobank
Newcastle University Protein & Proteome Analysis (NUPPA) Facility – specialised in Proteomics, Biological Mass Spec, Biophysics and Protein Production. For more information, please see:https://www.ncl.ac.uk/nuppa/
Newcastle University Electron Microscopy Research Services – provides access to state-of-the-art facilities, full technical support , training and collaboration. For more information please see: https://www.ncl.ac.uk/emrs
Newcastle University Bio-screening Facility – Provides access to robotics and reagents to ask bespoke questions. Expertise in data analysis provide users assistance in interrogating their data. For more information please see: https://www.ncl.ac.uk/bsf
Newcastle University Preclinical In Vivo Imaging (PIVI) Facility – provides state-of-the-art imaging technology and expertise to aid disease monitoring. For more information please see: https://www.ncl.ac.uk/pivi
Newcastle University Flow Cytometry and High Plex Tissue Imaging Core Facility – provides access, training and services in high plex tissue imaging (spatial proteomics) and flow cytometry for assay development, discovery science and clinical trials. For more information please see: https://www.ncl.ac.uk/fccf
Newcastle University Structural Biology Facility – offers cutting-edge tools to solve complex protein structures, empowering breakthroughs in structural biology. For more information please see: https://nusbf.ncl.ac.uk
Newcastle University Research Facilities – Infectious Diseases Facility – Provides state-of-the-art facilities for early-phase discovery, assay development, and research support enabling safe work with hazard group 3 infectious biological material. For more information please see: https://www.ncl.ac.uk/nuidf
Newcastle University Bioimaging unit – provides access to microscopes for simple test assays through to high throughput screens suitable for drug identification, as well as providing advice on set up of such assays. Post acquisition, we can aid with data storage and analysis pipelines. For more information please see: https://www.ncl.ac.uk/bioimaging
Newcastle University Image analysis unit – From photography to super resolution microscopy, any imaging technology is supported, with experience in diverse themes including cellular microscopy and preclinical imaging. For more information please see: https://www.ncl.ac.uk/bioimaging/imageanalysisunit
Newcastle University Infectious Diseases Facility – Provides state-of-the-art facilities for early-phase discovery, assay development, and research support enabling safe work with hazard group 3 infectious biological material. For more information please see: https://www.ncl.ac.uk/nuidf

Novopath

+

NovoPath can support early-stage research through the provision of well annotated clinical samples from their biobank. Samples can be accessed through the extensive diagnostic archive, or prospectively collected to meet researcher needs.

NIHR HRC

+

The NIHR HRC conduct systematic literature reviews to support background research. Find out more here – https://hrc-techeval.nihr.ac.uk/

NIHR Research Support Service (RSS)

+

The RSS provides expert support and advice to applied health, public health, social care, and industry researchers on the design and delivery of research and the development of research funding applications. They can support with research evidence for grants, funding applications, pitches and proposals. For further information, please see: https://www.nihr.ac.uk/support-and-services/research-support-service/rss-hub-newcastle

The “intended purpose” (also called “intended use”) of a medical device or in vitro diagnostic (IVD) is a formal statement provided by the manufacturer that defines what the device is designed to do, who it is for, how and where it should be used, and under what conditions.

The intended purpose of an innovation should be considered very early in diagnostic development as it informs which regulations and standards apply and can impact study design, and where the device can be sold.

Why it matters

−

It determines regulatory classification and what level of evidence is needed.
It guides performance evaluation and clinical validation.
It ensures the device is used safely and correctly within its approved scope.
It’s central to labelling, CE/UKCA marking, and marketing.

The following teams provide services to support this phase of diagnostic development. Click each team below to find out more.

NIHR HRC

−

The NIHR HRC have expertise in early stakeholder engagement. From this work we can generate potential “use cases” for the new technology and explore changes to clinical decision-making if the test was to be introduced in clinical practice. This work feeds into other research and development including identifying value propositions and design of the device and clinical studies. Find out more here – https://hrc-techeval.nihr.ac.uk/

The Newcastle Hospitals Medical Device Development Service (MDDS)

+

The Newcastle Hospitals Medical Device Development Service (MDDS) offers support in formulating the intended purpose of a medical device. For further information, please see: https://www.newcastle-hospitals.nhs.uk/services/medical-physics/medical-device-development-service

Health Innovation North East North Cumbria

+

Health Innovation North East North Cumbria work with innovators and the health and care system to understand use cases and whether there is an opportunity to provide the system a better alternative or a new solution that will demonstrate system and patient impact. For further information please see: https://healthinnovationnenc.org.uk/

NIHR Research Support Service (RSS)

+

The RSS provides expert support and advice to applied health, public health, social care, and industry researchers on the design and delivery of research and the development of research funding applications. They support researchers/SMEs with research evidence. For further information please visit: https://www.nihr.ac.uk/support-and-services/research-support-service/rss-hub-newcastle

All ideas for new, or replacement diagnostic innovations should start with a clearly identified unmet need. This avoids developing a test that is scientifically impressive, but clinically irrelevant. Starting with identifying an unmet clinical need will increase the likelihood of clinical useful design and successful adoption.

Unmet need

−

An unmet need in clinical diagnostics refers to a gap where current diagnostic tools or methods are insufficient, unavailable, or inefficient in accurately detecting, monitoring, or predicting a disease or condition—especially in ways that would improve patient outcomes, clinical decision-making, or healthcare efficiency.

Unmet needs may be identified in several ways, for example through clinical or patient insights, through data analysis (e.g. using real-world evidence to spot missed diagnoses, delays in diagnosis, or health economics analysis)

The following teams provide services to support this phase of diagnostic development. Click each team below to find out more.

NIHR HRC

−

The NIHR HRC have expertise in identifying and eliciting unmet clinical needs across all settings and aspects of healthcare, from community care to tertiary referrals. They then develop a list of ideal characteristics for new diagnostics that could help to tackle these challenges. Find out more here – https://hrc-techeval.nihr.ac.uk/

NIHR Innovation Observatory

+

The NIHR Innovation Observatory conduct horizon scanning on behalf of stakeholders to identify and assess unmet needs. Find out more here: https://io.nihr.ac.uk/

Health Innovation North East and North Cumbria

+

Health Innovation North East North Cumbria work with our local health and care sector to identify problems and where appropriate run unmet need challenges to identify innovations to support the system. They have a defined process to identify, articulate and deliver unmet need calls regionally and nationally.

For further information please see: https://healthinnovationnenc.org.uk/

NIHR Research Support Service (RSS)

+

The RSS provides expert support and advice to applied health, public health, social care, and industry researchers on the design and delivery of research and the development of research funding applications. They can provide commercialisation overview to highlight unmet market needs. For further information please see: https://www.nihr.ac.uk/support-and-services/research-support-service/rss-hub-newcastle

This stage is vital to identify requirements such as:

Technical requirements:
- performance specifications e.g. Limit of detection, turn-around time, stability, accuracy
- sample requirements (e.g. type – blood, saliva, urine, swab, tissue etc)
- instrumentation and workflows – will the test be automatic, manual, semi-automated?
Software requirements – systems integration, data security, connectivity
User and usability requirements
Information – labelling, packaging and instructions for use
Regulatory and quality requirements:
- Compliance standards (e.g. ISO, CLIA) – biological safety, sterility, electrical/mechanical/radiation safety.
- Regulatory pathway e.g. CE, UKCA, FDA

Identify requirements

−

This stage is vital to identify requirements such as:

Technical requirements –
- performance specifications e.g. Limit of detection, turn-around time, stability.
- sample requirements (e.g. type – blood, saliva, urine, swab, tissue etc)
- Instrumentation and workflows – will the test be automatic, manual, semi-automated? Software requirements? Connectivity
Regulatory and quality requirements
Regulatory pathway e.g. UKCA, FDA
Compliance standards (e.g. ISO, CLIA)
Labelling and instructions for use

The following teams provide services to support this phase of diagnostic development. Click each team below to find out more.

The Newcastle Hospitals Medical Device Development Service (MDDS)

−

The Newcastle Hospitals Medical Device Development Service (MDDS) provides support in identifying medical device users and other stakeholders and eliciting their requirements. They also help identifying relevant regulations and standards and extracting relevant requirements from these. For further information, please see: https://www.newcastle-hospitals.nhs.uk/services/medical-physics/medical-device-development-service

Market analysis & business planning are crucial to the successful development of a clinical diagnostic. This stage is focussed on determining the commercial viability of a diagnostic test and establishing a strategic plan for development, marketing and commercialisation.

Market Analysis & Business Planning

−

Market analysis & business planning play an important role to:

Identify the target market– defining the patient population and clinical setting (e.g. hospital, clinics, point-of-care)
Estimating the market size – In terms of number of tests and potential revenue.
Map stakeholders– For example, clinicians, lab directors, procurement leads, to help understand their decision-making process, adoption drivers etc.
Identify competitors – By identifying and comparing competitor solutions ( e.g. in terms of accuracy, turn-around time, cost and useability)
Understand the regulatory landscape – To inform regulatory pathway choices (e.g. CE/UKCA marking class)
Support pricing, reimbursement and return on investment – modelling costs, pricing strategies, and if it is financially sustainable
Attract investment – through strong business cases to secure funding
Protect – Identifying areas where Intellectual property (IP) should be secured.

The following teams provide services to support this phase of diagnostic development. Click each team below to find out more.

Newcastle Joint Research Office

−

The NJRO supports researchers through funding development (commercial and non-commercial), governance and regulatory compliance (from low-risk observational studies to high-risk international clinical trials), application submission, post-award contracting and intellectual property (IP) and post-award project management. For more information, see: https://newcastlejro.com/

Health Innovation North East North Cumbria

+

Health Innovation North East North Cumbria provide market research and horizon scans to support business planning and development of innovations. For further information please see: https://healthinnovationnenc.org.uk/

NIHR Research Support Service (RSS)

+

The RSS provides expert support and advice to applied health, public health, social care, and industry researchers on the design and delivery of research and the development of research funding applications. They can help with commercialisation review of applications and signposting to partners in the business support ecosystem and HLS sector. For further information, please visit: https://www.nihr.ac.uk/support-and-services/research-support-service/rss-hub-newcastle

A Target Product Profile is like a blueprint or wish list for a new diagnostic test. It sets out what the ideal test should do, who it’s for, and how it will be used in real-world healthcare.

A TPP typically describes things like

−

What the test is for (e.g., early detection of bowel cancer)
Who it’s for (e.g., people with vague symptoms in primary care)
How fast it needs to give results
How accurate it must be (e.g., sensitivity, specificity)
Where it will be used (e.g., in GP surgeries or hospitals)
How much it should cost to be affordable and usable

The following teams provide services to support this phase of diagnostic development. Click each team below to find out more.

NIHR HRC

−

The NIHR HRC help to develop ‘blueprints’ of the ideal minimal and optimal characteristics for new diagnostics that could help to tackle the unmet needs in that system as determined by patients and healthcare professionals. This is known as a “Target Product Profile”. This document helps developers to shape the design of their diagnostics at an early stage and indicates the preferences of healthcare professionals working in that space. Find out more here – https://hrc-techeval.nihr.ac.uk/

The “value proposition” phase in clinical diagnostic development is when you define why your diagnostic matters—to patients, clinicians, payers, and healthcare systems—and what benefits it offers compared to current solutions.

Value Proposition

−

Creating a clearly articulated value proposition is vital to communicate the benefits of your innovation

Clinical value – Does it improve detection, diagnosis or treatment decisions?
Patient value – Is it faster, less invasive, more accessible, or more accurate? Is there equity and ease of access?
Health system value – Can it reduce hospital visits, speed up triage, or cut downstream costs?
Economic value – Is it cost effective? Will it be reimbursed?
Workflow fit – Can it easily be integrated into existing clinical workflows? (Care Pathway analysis)
Differentiation – How is it better that what’s already available?

The following teams provide services to support this phase of diagnostic development. Click each team below to find out more.

NIHR HRC

−

The NIHR HRC have expertise in care pathway analysis to identify scenarios where a new technologies could have the best benefit on patient care. We use this research, which can include engagement with patients and clinicians, to help developers identify and assess the value proposition of the technology. This work also highlights barriers and facilitators to adoption. For more information, please see: https://hrc-techeval.nihr.ac.uk/

Health Innovation North East and North Cumbria

+

Health Innovation North East North Cumbria have a well-defined process for helping innovators to articulate and validate their value proposition to the NHS and social care. For further information please see: https://healthinnovationnenc.org.uk/

Newcastle University Image analysis unit

+

Our software and hardware access allows us to work easily across a variety of imaging modalities, and we have direct experience working with ultrasound images, CT scans, and MRI scans to provide custom analysis pipelines for quantitative analyses. For more information please see: https://www.ncl.ac.uk/bioimaging /imageanalysisunit

NIHR Research Support Service (RSS)

+

The RSS provides expert support and advice to applied health, public health, social care, and industry researchers on the design and delivery of research and the development of research funding applications. They provide support and guidance on the inclusion in applications. For further information, please visit: https://www.nihr.ac.uk/support-and-services/research-support-service/rss-hub-newcastle

Health economics looks at how we spend money on health and healthcare, and how to get the best value for that money.

Health Economics

−

Health economics helps answer questions like

Which treatments give the most benefit for their cost?
How can we make healthcare affordable for everyone?
Should a new, expensive drug be paid for by the health system?

Data is used to support:

Government & health systems – to decide which diagnostic tests to fund or include in guidelines
Hospitals and clinics – to choose which tests to offer and when
Health insurers – to decide what tests to cover
Researcher and test developers – to prove that new tests are worth the cost and improve patient care.

The following teams provide services to support this phase of diagnostic development. Click each team below to find out more.

NIHR HRC

−

The NIHR HRC have expertise in generating health economics evidence on new diagnostics including early economic modelling, cost-effectiveness analysis and budget impact analysis which is suitable for NICE appraisals. For more information please see: https://hrc-techeval.nihr.ac.uk/

NIHR Research Support Service (RSS)

+

The RSS provides expert support and advice to applied health, public health, social care, and industry researchers on the design and delivery of research and the development of research funding applications. They support on HE for research and funding applications. For further information, please visit: https://www.nihr.ac.uk/support-and-services/research-support-service/rss-hub-newcastle

Regulatory certification is an essential, and often challenging aspect of diagnostic development. All diagnostic developers must meet a strict set of regulatory requirements to enable their innovation to be adopted within the UK, with different requirements for international markets.

Regulatory Certification

−

The purpose of regulatory approval is to ensure the test meets safety, quality, and performance requirements. The regulation is dependent on the type of innovation being developed e.g. MedTech, Digital Technology.

UKCA marking (UK Conformity Assessed marking) is a certification mark used for products being placed on the market in Great Britain (England, Scotland, and Wales). It indicates that a product conforms to the UK regulations and standards for safety, health, and environmental protection.

This is not recognized in the EU, EEA, or Northern Ireland (where CE marking is applied).

Northern Ireland uses UKNI marking alongside CE if UK bodies are involved. Separate requirements apply to the USA and other countries.

The following certification bodies can help with regulatory certification: UK approved bodies, and EU notified bodies.

The following teams at DxNE can support the regulatory certification process are:

The North East Innovation Lab (NEIL)

−

The North East Innovation Lab (NEIL) can provide independent evaluations and evidence to support regulatory applications. The evidence provided is often used in CE and UKCA marking of IVDs, as well as submissions to the CDTA and FDA, and to satisfy compliance with MHRA and IVDR. For more information please see: https://commercial.newcastle-hospitals.nhs.uk/our-services/innovation-lab/

Health Innovation North East North Cumbria

+

Health Innovation North East North Cumbria can offer advice on the most appropriate regulatory route for an innovation.. For further information please see: https://healthinnovationnenc.org.uk/

The Newcastle Hospitals Medical Device Development Service (MDDS)

+

The Newcastle Hospitals Medical Device Development Service (MDDS) supports regulatory certification by providing advice on CE/UKCA-marking pathways and the evidence requirements for these. For further information, please see: https://www.newcastle-hospitals.nhs.uk/services/medical-physics/medical-device-development-service

NIHR HRC

+

The NIHR HRC provide developers with advice and guidance for putting a medical device or diagnostic into service in the UK. We do this by working with groups to help developers identify applicable standards and guidance associated with their device, and by signposting them to companies who can help them develop their regulatory submission to the MHRA. For more information please see: https://hrc-techeval.nihr.ac.uk

NIHR Research Support Service (RSS)

+

The RSS provides expert support and advice to applied health, public health, social care, and industry researchers on the design and delivery of research and the development of research funding applications. For further information please visit: https://www.nihr.ac.uk/support-and-services/research-support-service/rss-hub-newcastle

Market access and launch is a critical final phase in the clinical diagnostic development process where the focus shifts from development and validation to introducing the product into the healthcare system and ensuring it is adopted, reimbursed, and used effectively. It combines elements of regulatory readiness, commercialization, pricing strategy, and stakeholder engagement.

Market access - launch

−

The launch of new diagnostic innovations may develop as a regional, national, or international launch – with initial pilots, followed by spread and widespread adoption.

Activities include

Engaging with healthcare providers and payers
Education, training and evidence sharing
Inclusion in clinical guidelines and electronic health record systems

The outcome should be the test being adopted into routine practice.

The following teams provide services to support this phase of diagnostic development. Click each team below to find out more.

Health Innovation North East North Cumbria

−

Health Innovation North East North Cumbria have a well-defined process for developing business cases and market access plans and strategies both locally and nationally. For further information please see: https://healthinnovationnenc.org.uk/

NIHR Research Support Service (RSS)

+

The RSS provides expert support and advice to applied health, public health, social care, and industry researchers on the design and delivery of research and the development of research funding applications. For further information please visit: https://www.nihr.ac.uk/support-and-services/research-support-service/rss-hub-newcastle

The NHS implementation step in clinical diagnostic development refers to the complex process of integrating a new diagnostic test into routine clinical practice within the UK’s National Health Service (NHS). This step is often considered one of the most challenging and resource-intensive, as it involves navigating real-world logistics, clinical acceptance, commissioning, and sustained funding.

NHS Implementation

−

Post Market Surveillance is a vital component of development, monitoring the performance, outcomes and identifying areas for improvement.

Real World Data (RWD) is collected on the use of the diagnostic in practice to ensure the continued validation, improvement and credibility of the test.

The following teams provide services to support this phase of diagnostic development. Click each team below to find out more.

Health Innovation North East North Cumbria

−

Health Innovation North East North Cumbria work closely with the NHS and social care teams to support deployment of well-evidenced innovation which includes evaluation. For further information please see: https://healthinnovationnenc.org.uk/

Post marketing surveillance refers to the ongoing process of systematically collecting, analysing, and evaluating real-world data on diagnostic tests once they’re in routine clinical use.

Aim

−

The aim of post marketing surveillance is to:

Confirm that the test performs safely and effectively outside controlled development environments
Detect rare issues, incorrect usage, or performance drift
Identify new side effects or off-label usage
Update risk–benefit assessments and technical documentation

The following teams provide services to support this phase of diagnostic development. Click each team below to find out more.

Health Innovation North East North Cumbria

−

Health Innovation North East North Cumbria provides regional diagnostic performance surveillance via digital systems. For further information please see: https://healthinnovationnenc.org.uk/

The Newcastle Hospitals Medical Device Development Service (MDDS)

+

The Newcastle Hospitals Medical Device Development Service (MDDS) can support development of safety monitoring and post market surveillance plans, and post-market surveillance reports. For further information, please see:

https://www.newcastle-hospitals.nhs.uk/services/medical-physics/medical-device-development-service/

Patient and Public Involvement and Engagement (PPIE)

We recommend involving and engaging with patients and the public throughout your work to help ensure that your new diagnostic will benefit all relevant populations.

You are also required to demonstrate how you will intentionally embed and include diverse public in your research when applying for research funding and seeking ethical and regulatory approvals.

Definitions

Our patient and public involvement and engagement is aligned to the NIHR definitions.

Public: includes patients, potential patients, carers, people with lived experience of a health condition(s), and communities and organisations who represent people who use health and social care services.
Involvement: is the active involvement of the public in research projects and in research organisations, where research is carried out ‘with’ or ‘by’ members of the public rather than ‘to’, ‘about’ or ‘for’ them.
Engagement: where information and knowledge about research is provided and disseminated.

Research Inclusion is the effort to involve a variety of people in research to reduce biases and ensure a diverse perspective.

Patient and Public Involvement and Engagement (PPIE) and Research Inclusion (RI) apply to the whole research cycle and therefore need to be embedded from the earliest stages of developing a research idea to the design, delivery and dissemination of the research.

The following teams provide services to support this phase of diagnostic development. Click each team below to find out more.

NIHR HealthTech Research Centre (HRC) in Diagnostic and Technology Evaluation

−

The NIHR HealthTech Research Centre (HRC) in Diagnostic and Technology Evaluation can advise and offer support around PPIE and RI.

For more information about the HRC visit: https://hrc-techeval.nihr.ac.uk

The HRC approach to PPIE: https://hrc-techeval.nihr.ac.uk/patients-carers-public/

The HRC approach to RI: https://hrc-techeval.nihr.ac.uk/for-collaborators/research-inclusion/

Patient and Public Involvement and Engagement (PPIE) – Newcastle Health Research Partnership

Voice: Voice UK

Biobanking

Biobanking is the process of collecting, processing, storing, and distributing biological samples — such as blood, tissue, saliva, DNA, or other bodily materials — for use in research, clinical trials, diagnostics, or public health studies.

In Newcastle we provide access to a wide range of high quality, data rich human tissue samples for use in research. Samples can be accessed via the vast diagnostic archive in Newcastle Hospitals, or new samples can be collected prospectively to meet research needs.

The following teams provide services to support this phase of diagnostic development. Click each team below to find out more.

Newcastle upon Tyne Hospitals NHS Foundation Trust

−

The Newcastle Hospitals Biobank has HRA research ethics committee (REC) approval to collect and provide access to valuable clinical samples to support health and life science research. Specifically, these samples are collected from patients of Newcastle Hospitals, including access to the hospital’s vast diagnostic archive. Additional sample processing, support for diagnostic development and specialist pathology services are also available.

A comprehensive range of samples can be provided by disease state, by tissue type or bespoke prospective collections to suit individual requirements. For more information see:

Find out more

Newcastle University Research Facilities

+

The Newcastle Central Biobank Facility offers sample storage facilities to support translational research.

Find out more

	Examples / Bodies
Quality Standards	ISO 13485, ISO 15189, ISO 14971
Device Regulation	UKCA, CE, IVDR, MHRA
Human Tissue Use	Human Tissue Act (2004)
Data Protection	UK GDPR, Data Protection Act 2018
Ethics and Governance	Research Ethics Committees, (NHS Health Research Authority)

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Welcome to the Diagnostics North East Directory of Service

About our directory

Our Directory

Search the Directory

Discovery

Development

Evaluation

Adoption

TRL1

TRL2

TRL3

TRL4

TRL5

TRL6

TRL7

TRL8

TRL9

Meet the Teams!

Newcastle University Research Facilities

Why is it important?

Purpose

Why it matters

Unmet need

Identify requirements

Market Analysis & Business Planning

A TPP typically describes things like

Prototype development

Value Proposition

Pre-Clinical Evidence Generation

Health Economics

Clinical Evidence Generation

Regulatory Certification

Market access - launch

NHS Implementation

Aim

Get in touch

Directory of Service

Welcome to the Diagnostics North East Directory of Service

About our directory

Our Directory

Search the Directory

Discovery

Development

Evaluation

Adoption

TRL1

TRL2

TRL3

TRL4

TRL5

TRL6

TRL7

TRL8

TRL9

Meet the Teams!

Newcastle University Research Facilities

Why is it important?

NIHR Innovation Observatory

Health Innovation North East North Cumbria

Purpose

Newcastle University Research Facilities

Novopath

NIHR HRC

NIHR Research Support Service (RSS)

Why it matters

NIHR HRC

The Newcastle Hospitals Medical Device Development Service (MDDS)

Health Innovation North East North Cumbria

NIHR Research Support Service (RSS)

Unmet need

NIHR HRC

NIHR Innovation Observatory

Health Innovation North East and North Cumbria

NIHR Research Support Service (RSS)

Identify requirements

The Newcastle Hospitals Medical Device Development Service (MDDS)

Market Analysis & Business Planning

Newcastle Joint Research Office

Health Innovation North East North Cumbria

NIHR Research Support Service (RSS)

A TPP typically describes things like

NIHR HRC

Prototype development

North East Innovation Lab

Novopath

NIHR HRC

Health Innovation North East and North Cumbria

The Newcastle Hospitals Medical Device Development Service (MDDS)

Newcastle Central Biobank Facility

Newcastle University Image analysis unit

Value Proposition

NIHR HRC

Health Innovation North East and North Cumbria

Newcastle University Image analysis unit

NIHR Research Support Service (RSS)

Pre-Clinical Evidence Generation

Novopath

The North East Innovation Lab (NEIL)

Health Innovation North East North Cumbria

The Newcastle Hospitals Medical Device Development Service (MDDS)

NIHR HRC

Newcastle University Research Facilities

Health Economics

NIHR HRC

NIHR Research Support Service (RSS)

Clinical Evidence Generation

NIHR HRC

The North East Innovation Lab (NEIL)

MedConnect North

NIHR Innovation Observatory

Novopath

NJRO

Health Innovation North East North Cumbria

The Newcastle Hospitals Medical Device Development Service (MDDS)

Newcastle Central Biobank Facility

NIHR Research Support Service (RSS)